Medicare Enrolled

Dr. Diego Maldonado, M.D.

Pulmonary Disease · Vero Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1000 36TH ST, Vero Beach, FL 32960
7727945800
In practice since 2007 (18 years)
NPI: 1568673630 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maldonado from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maldonado? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maldonado

Dr. Diego Maldonado is a pulmonary disease in Vero Beach, FL, with 18 years in practice. Based on federal Medicare data, Dr. Maldonado performed 3,077 Medicare services across 2,399 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maldonado received a total of $230,690 from 31 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maldonado is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 17% volume in FL$ $230,690 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,077
Medicare services
Top 17% in FL for pulmonary disease
2,399
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~171 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,082$77$206
Test to measure expiratory airflow and volume changes before and after medication administration246$8$542
Test to examine how well the lungs exchange gases243$7$22
Test to determine lung volumes using gas dilution or washout242$9$29
Hospital follow-up visit, high complexity210$96$242
Test to measure expiratory airflow and volume194$7$82
Critical care, first 30-74 min144$180$649
New patient office visit (45-59 min)136$103$306
Initial hospital admission, high complexity129$143$1,039
Office visit, established patient, complex (40-54 min)128$115$240
Office visit, established patient (20-29 min)65$50$170
Smoking and tobacco use intensive counseling, 4-10 minutes63$12$31
Test for exercise-induced lung stress57$16$87
Aspiration of initial secretion of lung airway using an endoscope49$92$1,616
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes29$11$117
Irrigation and suction of lung airways to obtain cells using an endoscope23$10$583
Critical care, each additional 30 minutes21$91$279
Aspiration of fluid from chest cavity using imaging guidance16$91$2,689
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$230,690
Total received (2018-2024)
Avg $32,956/year across 7 years
Top 2% in FL for pulmonary disease
31
Companies
343
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$210,811 (91.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,715 (5.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,165 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$51,773
2023
$77,540
2022
$36,277
2021
$20,529
2020
$14,396
2019
$22,068
2018
$8,107

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$116,569
Actelion Pharmaceuticals US, Inc.
$34,857
Mylan Specialty L.P.
$28,566
Bayer HealthCare Pharmaceuticals Inc.
$21,651
Bayer Healthcare Pharmaceuticals Inc.
$11,516
United Therapeutics Corporation
$6,574
Pulmonx Corporation
$3,168
Johnson & Johnson Health Care Systems Inc.
$2,355
Gilead Sciences, Inc.
$1,935
Ethicon Inc.
$830
Veran Medical Technologies, Inc.
$737
BOSTON SCIENTIFIC CORPORATION
$539
AstraZeneca Pharmaceuticals LP
$498
Medical Device Business Services, Inc.
$114
Genentech USA, Inc.
$99
PFIZER INC.
$99
Auris Health, Inc.
$85
Inspire Medical Systems, Inc.
$72
Covidien LP
$71
Regeneron Healthcare Solutions, Inc.
$67
Insmed, Inc.
$50
GENZYME CORPORATION
$42
Amgen Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$28
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$26
Penumbra, Inc.
$24
Merck Sharp & Dohme LLC
$22
ABBVIE INC.
$21
ICU Medical Inc
$17
Ambu Inc.
$12
Grifols USA, LLC
$11
Top 3 companies account for 78.0% of total payments
Associated products mentioned in payments ›
ACQUIRE · AREXVY · Adempas · Arikayce · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · COREDX · DUPIXENT · ELIQUIS · Esbriet · FASENRA · GENERAL THERAPIES · GLASSIA · INSPIRE · Indigo System · Letairis · LifeVest · MAVYRET · Monarch · Monarch Platform · NUCALA · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C · Pulmonx Endobronchial Valve EBV · Spin · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Tracheostomy · UPTRAVI · WINREVAIR · Xofigo · Xolair · YUPELRI · Yupelri · ZEPHYR ENDOBRONCHIAL VALVE · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in FL.

Equivalent to $7,497 per 100 Medicare services performed
Looking for a pulmonary disease in Vero Beach?
Compare pulmonary diseases in the Vero Beach area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
14
Per 100K population
8.5
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Maldonado is a clinical cardiology specialist, with above-average Medicare volume (top 17% in FL), and high industry engagement (speaking/promotional, top 2%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Maldonado experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Maldonado performed 1,082 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maldonado receive payments from pharmaceutical companies?
Yes. Dr. Maldonado received a total of $230,690 from 31 companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maldonado's costs compare to other pulmonary diseases in Vero Beach?
Dr. Maldonado's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maldonado) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →